Allstate (NYSE:ALL) Stock Price Expected to Rise, UBS Group Analyst Says

Allstate (NYSE:ALL) had its price objective boosted by analysts at UBS Group from $216.00 to $225.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the insurance provider’s stock. UBS Group’s target price indicates a potential upside of 21.60% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Barclays raised their target price on Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a report on Thursday, October 31st. BMO Capital Markets raised their target price on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Keefe, Bruyette & Woods raised their target price on Allstate from $199.00 to $208.00 and gave the company an “outperform” rating in a report on Monday, August 12th. Wells Fargo & Company reduced their target price on Allstate from $177.00 to $175.00 and set an “equal weight” rating for the company in a report on Friday, August 16th. Finally, StockNews.com downgraded Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Allstate has a consensus rating of “Moderate Buy” and a consensus target price of $208.44.

Allstate Price Performance

Shares of NYSE ALL opened at $185.03 on Monday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The stock has a fifty day moving average price of $188.85 and a 200 day moving average price of $175.50. Allstate has a 1-year low of $127.93 and a 1-year high of $198.79. The company has a market cap of $49.00 billion, a PE ratio of 11.98, a P/E/G ratio of 1.73 and a beta of 0.48.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same period last year, the company earned $0.81 earnings per share. The company’s revenue for the quarter was up 14.7% on a year-over-year basis. Sell-side analysts forecast that Allstate will post 15.23 EPS for the current year.

Insider Buying and Selling at Allstate

In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at $3,431,901.67. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock worth $34,967,665 in the last 90 days. 1.80% of the stock is owned by company insiders.

Institutional Trading of Allstate

A number of institutional investors and hedge funds have recently bought and sold shares of the business. SPC Financial Inc. boosted its stake in Allstate by 3.6% during the third quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock valued at $297,000 after buying an additional 54 shares in the last quarter. Lake Street Advisors Group LLC boosted its stake in Allstate by 1.8% during the third quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock valued at $596,000 after buying an additional 54 shares in the last quarter. Abacus Planning Group Inc. boosted its stake in Allstate by 2.4% during the third quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock valued at $458,000 after buying an additional 56 shares in the last quarter. Chicago Partners Investment Group LLC boosted its stake in Allstate by 1.3% during the third quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after buying an additional 59 shares in the last quarter. Finally, Carmichael Hill & Associates Inc. boosted its stake in Allstate by 15.0% during the third quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after buying an additional 60 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.